0001104659-22-071945.txt : 20220616 0001104659-22-071945.hdr.sgml : 20220616 20220616163927 ACCESSION NUMBER: 0001104659-22-071945 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220614 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferguson Kenneth M. CENTRAL INDEX KEY: 0001934344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 221021122 MAIL ADDRESS: STREET 1: 2125 1ST AVENUE #2902 CITY: SEATTLE STATE: WA ZIP: 98121-2121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2218645d8_4.xml FORM 4 X0306 4 2022-06-14 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001934344 Ferguson Kenneth M. C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 1 0 0 0 Common Stock 2022-06-14 4 A 0 27733 0 A 27733 D Stock Option (right to buy) 1.11 2022-06-14 4 A 0 47467 0 A 2023-06-14 2032-06-14 Common Stock 47467 47467 D The Reporting Person received an award of 27,733 restricted stock units on June 14, 2022, which shall vest in three equal installments on June 14, 2023, June 14, 2024, and June 14, 2025. The option will vest and become exercisable in equal monthly installments for thirty-six months beginning on the date of the grant, which is June 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date. These options were granted to Mr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. /s/ Kenneth M. Ferguson 2022-06-16